Blog
Guide pratiche per i protocolli di peptidi.
Contenuti divulgativi su monitoraggio, calcoli di dosaggio, conservazione, analisi del sangue e progettazione dei protocolli. Ogni articolo è rivisto da una persona ed è privo di consigli medici.
Le guide sono scritte in inglese.
Tutte le 143 guide sui peptidi
Cerca per nome, oppure tocca un beneficio per trovare il peptide giusto per quello che ti serve.
Filtra per beneficio
Mostrate 24 di 142 guide sui peptidi.
MK-677 (Ibutamoren): A Tracking Guide for an Oral GH Secretagogue
A measured, harm-reduction look at MK-677, what it actually does to GH and IGF-1, and the daily signals and bloodwork worth watching.
Utile per
Oral Semaglutide 25 mg: A Tracking Guide for the Wegovy Pill
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
Utile per
Ostarine (MK-2866): A Tracking Guide for the Most-Studied SARM
A neutral, harm-reduction look at ostarine, why it is the mildest of the SARMs, and what to monitor given it still suppresses natural hormones.
Utile per
CagriSema: A Tracking Guide for a Cagrilintide and Semaglutide Combination
A harm-reduction look at CagriSema, an investigational amylin-plus-GLP-1 combination not yet approved, and what would be worth tracking.
Utile per
Ligandrol (LGD-4033): A Tracking Guide for a Potent Mass-Building SARM
A harm-reduction look at ligandrol, why its strength comes with strong hormonal suppression, and the monitoring that actually matters.
Utile per
Mazdutide: A Tracking Guide for a Glucagon and GLP-1 Dual Agonist
A neutral, harm-reduction guide to mazdutide, a dual glucagon/GLP-1 agonist approved in China, and what to monitor.
Utile per
RAD-140 (Testolone): A Tracking Guide for a Strong Lean-Mass SARM
A harm-reduction look at RAD-140, its strong anabolic effect, the reported liver-injury signals, and what to monitor closely.
Utile per
Survodutide: A Tracking Guide for a GLP-1 and Glucagon Dual Agonist
A harm-reduction look at survodutide, an investigational GLP-1/glucagon agonist with obesity and MASH data, not yet approved.
Utile per
Cardarine (GW-501516): A Tracking Guide for a PPAR-Delta Agonist
A candid, harm-reduction look at cardarine, its endurance and fat-oxidation effects, and the rodent carcinogenicity signal that ended its development.
Utile per
Amycretin: A Tracking Guide for a GLP-1 and Amylin Agonist
A neutral, harm-reduction guide to amycretin, an investigational GLP-1/amylin agonist in oral and injectable forms, entering Phase 3.
Utile per
Andarine (S4): A Tracking Guide for an Older Cutting SARM
A harm-reduction look at andarine, its use in cutting phases, and the reversible vision side effect that sets it apart from other SARMs.
Utile per
VK2735: A Tracking Guide for a GIP and GLP-1 Dual Agonist
A harm-reduction look at VK2735, an investigational GIP/GLP-1 agonist in oral and injectable Phase 3 programs, not yet approved.
Utile per
YK-11: A Tracking Guide for a Steroidal Myostatin-Claim Compound
A harm-reduction look at YK-11, a steroidal compound sold as a SARM with myostatin-inhibition claims, and why the human evidence is essentially absent.
Utile per
Pemvidutide: A Tracking Guide for a GLP-1 and Glucagon Agonist
A neutral, harm-reduction guide to pemvidutide, an investigational GLP-1/glucagon agonist noted for lean-mass sparing and MASH data.
Utile per
Stenabolic (SR9009): A Tracking Guide for a REV-ERB Exercise Mimetic
A harm-reduction look at SR9009, its exercise-mimetic claims, and the poor oral bioavailability that undercuts most real-world use.
Utile per
Bimagrumab: A Tracking Guide for an Activin Receptor Antibody
A harm-reduction look at bimagrumab, an investigational antibody that lowers fat while preserving or adding muscle, studied with semaglutide.
Utile per
Enclomiphene: A Tracking Guide for a Fertility-Preserving SERM
A measured, harm-reduction look at enclomiphene, why it is used instead of exogenous testosterone, and the bloodwork that tells you whether it is working.
Utile per
Superdrol (Methasterone): A Tracking Guide for a Harsh Oral Steroid
A harm-reduction look at methasterone, a potent and markedly hepatotoxic oral steroid, and the monitoring that matters most if someone has already decided to use it.
Utile per
Cabergoline: A Tracking Guide for a Prolactin-Lowering Dopamine Agonist
A cautious, harm-reduction look at cabergoline, why it is used to manage prolactin, and the cardiac risk that has to be taken seriously.
Utile per
Halotestin (Fluoxymesterone): A Tracking Guide for a Potent Oral Androgen
A harm-reduction look at fluoxymesterone, a strong oral steroid used pre-competition for strength and aggression, with honest framing of its liver and lipid risks.
Utile per
Raloxifene: A Tracking Guide for a Gynecomastia-Focused SERM
A measured, harm-reduction look at raloxifene, why it is often preferred for treating gynecomastia, and the clotting risk to watch.
Utile per
Proviron (Mesterolone): A Tracking Guide for an Oral DHT Derivative
A measured look at mesterolone, a weakly anabolic oral DHT derivative used as an adjunct to lower SHBG and support libido, and what is worth tracking.
Utile per
Toremifene: A Tracking Guide for a Tamoxifen-Like SERM
A measured, harm-reduction look at toremifene, how it compares to tamoxifen, and what to monitor when it is used for gyno control or PCT.
Utile per
Trestolone (MENT): A Tracking Guide for a Potent 19-Nor Injectable
A harm-reduction look at trestolone, a very potent nandrolone-like injectable that is strongly suppressive and aromatizes to a potent estrogen, and what to monitor.
Utile per